Successful management of refractory staple line leakage at the esophagogastric junction after a sleeve gastrectomy using the HANAROSTENT

Takashi Oshiro, Kazunori Kasama, Akiko Umezawa, Eiji Kanehira, Yoshimochi Kurokawa

    Research output: Contribution to journalArticlepeer-review

    34 Citations (Scopus)

    Abstract

    The esophagogastric junction (EGJ) is a potential site of leakage after a sleeve gastrectomy which is usually difficult to treat conservatively. Two patients underwent a laparoscopic sleeve gastrectomy. A subphrenic abscess due to a staple line leakage was detected by CT at 3 weeks and 10 days after the operation, respectively. The abscess was drained laparoscopically. Intractable leakage required several endoscopic treatments, including clipping and sealing. However, a persisting fistula was found on radiographic studies. A covered self-expandable and retrievable stent (HANAROSTENT®) was finally placed over the leakage site at 15 and 6 weeks after the reoperation, respectively. Oral intake was achieved from poststent day 1, and they were discharged 2 weeks after stenting. Three months later, the stent was endoscopically removed and the leakage was successfully sealed. The HANAROSTENT is therefore considered to be a safe and effective therapeutic option for the management of staple line leakage at the EGJ.

    Original languageEnglish
    Pages (from-to)530-534
    Number of pages5
    JournalObesity Surgery
    Volume20
    Issue number4
    DOIs
    Publication statusPublished - 2010 Apr

    Keywords

    • Esophagogastric junction
    • HANAROSTENT
    • Sleeve gastrectomy
    • Staple line leakage

    ASJC Scopus subject areas

    • Surgery
    • Endocrinology, Diabetes and Metabolism
    • Nutrition and Dietetics

    Fingerprint Dive into the research topics of 'Successful management of refractory staple line leakage at the esophagogastric junction after a sleeve gastrectomy using the HANAROSTENT'. Together they form a unique fingerprint.

    Cite this